🔎 Trials Near Me

Home › Parkinson's Disease › NCT05822388

Cognitive Decline Following Deep Brain Stimulation

RecruitingObservational studyHealthy volunteers welcome

A Neural Basis for Cognitive Decline Following Deep Brain Stimulation

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
PD Participants

Inclusion Criteria:

* Subjects above 18 years of age
* Subjects who will undergo DBS surgery as part of their clinical care for PD

Exclusion Criteria:

* Uncorrected visual or hearing impairments, as indicated by self-report
* Individuals who are pregnant or expect to become pregnant during the course of the study
* Individuals with claustrophobia, or the inability to lie supine position in the MRI scanner
* COPD with oxygen dependence
* Non-MRI compatible metal implants (surgical clips or staples, cardiac pacemakers etc.)

Non-PD Control Participants

Inclusion Criteria:

* Subjects above 18 years of age
* Age matched to participants in PD group

Exclusion Criteria:

* Diagnosis of Parkinsons Disease or other movement disorder
* Untreated neuropsychiatric disorders
* Uncorrected visual or hearing impairments, as indicated by self-report
* Individuals who are pregnant or expect to become pregnant during the course of the study
* Individuals with claustrophobia, or the inability to lie supine position in the MRI scanner
* COPD with oxygen dependence
* Non-MRI compatible metal implants (surgical clips or staples, cardiac pacemakers etc.)

About the study

This research study aims to identify MRI-based brain biomarkers that predict an individual's response to Deep Brain Stimulation (DBS). In particular, this study will focus on changes in cognition associated with DBS. A total of 55 participants with Parkinson's Disease planning to undergo DBS will be recruited from MUSCs Clinical DBS Program. Participants will undergo four visits, including a 1-hour screening visit, a 1.5-hour pre-DBS MRI scanning visit, and a 3.5-hour post-DBS cognitive assessment visit. In addition control participants without Parkinson's Disease will be recruited to undergo MRI scanning and cognitive assessments.

What is being tested

Sponsor: Medical University of South Carolina · Participants: 80 · Started: Apr 1, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT05822388

Locations in the U.S.

South CarolinaMedical University of South Carolina, Charleston

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.